胸主动脉疾病TEVAR的IFU依从性与中期结局:GREAT注册研究
该研究基于GREAT前瞻性多中心注册的回顾性分析,纳入334例择期胸降主动脉瘤或穿透性主动脉溃疡行TEVAR的患者,比较遵循与偏离器械使用说明(IFU)的中期结局。5年随访显示,偏离IFU未显著增加生存率、主动脉相关死亡率或严重不良事件风险,但「其他」再干预风险显著升高。
要点
- 择期TEVAR中38%偏离IFU,常见原因为近端锚定区不足和远端直径不匹配。
- 偏离IFU未显著增加5年生存率、主动脉相关死亡率或严重不良事件风险。
- 偏离IFU患者「其他」再干预风险显著升高(HR 2.38,95%CI 1.13-5.02,P=0.022)。
核心结论
- 择期TEVAR常偏离IFU,主要受近端锚定区和远端直径限制。
- 偏离IFU未显著增加5年生存率、主动脉相关死亡率或主要器械相关并发症风险。
- 偏离IFU患者「其他」再干预风险显著升高,需谨慎选择患者并加强随访。
研究设计与样本
- 基于GREAT前瞻性多中心注册(NCT01658787)的回顾性分析。
- 纳入2010至2016年接受GORE® TAG®或Conformable TAG®器械的939例患者。
- 本分析纳入334例择期DTAA或PAU患者,TEVAR近端锚定区2-4,随访5年。
- 按遵循IFU(iIFU)或偏离IFU(oIFU)分组,主要终点包括生存率、主动脉相关死亡率、严重不良事件和器械/操作相关并发症。
主要发现
- 334例患者中位年龄71岁,女性41%;208例(62%)为iIFU,128例(38%)为oIFU。
- 常见偏离为近端锚定区不足(56%)和远端直径不匹配(47%)。
- 5年生存率iIFU 56.1% vs oIFU 62.8%(P=0.50),主动脉相关死亡率4.3% vs 4.7%(P=0.90)。
- 严重不良事件64.3% vs 61.4%(P=0.60),器械/操作相关严重不良事件24.0% vs 26.7%(P=0.60)。
- 再干预率iIFU 15% vs oIFU 20%(P=0.30);oIFU患者「其他」再干预风险显著升高(HR 2.38,95%CI 1.13-5.02,P=0.022)。
临床怎么用
- 择期TEVAR偏离IFU常见,不应仅因解剖偏离而拒绝手术,但需个体化评估。
- 偏离IFU患者应加强结构化随访,以便早期发现并处理再干预需求。
局限性
- 回顾性分析设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To examine whether adherence to device instructions for use (IFU) impacts outcomes after thoracic endovascular aortic repair (TEVAR) for descending thoracic aortic aneurysm (DTAA) and penetrating aortic ulcer (PAU). METHODS: This retrospective analysis of the prospective, multicenter Gore Global Registry for Endovascular Aortic Treatment (GREAT) (NCT01658787) included 939 patients treated with GORE® TAG® or Conformable TAG® devices between 2010 and 2016. For the present study, we evaluated 334 elective patients with DTAA or PAU who underwent TEVAR in proximal landing zones 2-4, with 5 years of follow-up (FU). Patients were categorized as treated inside IFU (iIFU) or outside IFU (oIFU). Primary outcomes included survival, aortic-related mortality, serious adverse events (SAEs), and device-/procedure-related complications. Secondary outcomes included endoleak, reintervention (RI), and device integrity. Cox proportional hazards models assessed associations between IFU status and outcomes. RESULTS: Among 334 patients (median age, 71 years; 41% female), 208 (62%) were treated iIFU and 128 (38%) oIFU. The most common deviations were inadequate proximal landing zone (56%) and distal diameter mismatch (47%). Baseline demographics and comorbidities were similar, although coronary heart disease was more prevalent in iIFU patients. Over 5 years, survival (56.1% vs. 62.8%, P = 0.50), aortic-related mortality (4.3% vs. 4.7%, P = 0.90), SAEs (64.3% vs. 61.4%, P = 0.60), and device-/procedure-related SAEs (24.0% vs. 26.7%, P = 0.60) did not differ significantly between iIFU and oIFU groups. Endoleaks were infrequent, with no significant differences by IFU status, though type III endoleaks occurred only in oIFU patients (1.6%). Device migration, fracture, or compression was rare. RIs occurred in 15% of iIFU and 20% of oIFU patients (P = 0.30). Cox analysis demonstrated a significantly increased hazard for "other" RIs in oIFU patients (hazard ratio, 2.38; 95% confidence interval, 1.13-5.02; P = 0.022), whereas risks for device-/procedure-related RIs, endoleaks, or mortality were not significantly different. CONCLUSION: Elective TEVAR is frequently performed oIFU, largely due to proximal landing zone and distal diameter constraints. In this multicenter registry, oIFU treatment was not associated with significantly worse survival, aortic-related mortality, or major device-related complications over 5 years. However, the increased risk of secondary RIs highlights the need for careful patient selection, structured FU, and further prospective research to define which anatomic deviations can be safely tolerated in clinical practice.
引用
- Meisenbacher K, Hagedorn MN, Böckler D, et al. Adherence to Instructions for Use and Mid-Term Outcomes of Endovascular Repair in Thoracic Aortic Disease from the Gore Global Registry for Endovascular Aortic Treatment (GREAT). Ann Vasc Surg. 2026. PMID: 41895591. doi:10.1016/j.avsg.2026.02.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。